Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluation

Journal of Urology

Volumn 168, Issue 6, 2002, Pages 2476-2482

  Noble, Sian M ^a,b   Coast, Joanna ^a,b   Brookes, Sara ^a,b   Neal, David E ^a,b   Abrams, Paul ^a,b   Peters, Tim J ^a,b   Donovan, Jenny L ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Costs and cost analysis; Lasers; Prostate; Prostatic hyperplasia; Transurethral resection of prostate

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE UTILIZATION; HUMAN; INTERMETHOD COMPARISON; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION; UNITED KINGDOM; URINE FLOW RATE;

EID: 0036893840     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64172-9     Document Type: Article

References (19)

1. McNicholas, T. A.: Management of symptomatic BPH in the UK: Who is treated and how? Eur Urol, 36: 33, 1999
2. Mebust, W. K., Holtgrewe, H. L., Cockett, A. T. K., Peters, P. C., and Writing Comlittee: Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutionr evaluating 3,885 patients. J Urol, 141: 243, 1989
3. Roos, N. P., Wennberg, J. E., Malenka, D. J., Fisher, E. S., McPherson, K., Anderson, T. F. et al: Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med, 320: 1120, 1989
4. Kortt, M. A. and Bootman, J. L.: The economics of benign prostatic hyperplasia treatment: A literature review. Clin Ther, 18: 1227, 1996
5. Donovan, J. L., Peters, T. J., Neal, D. E., Brookes, S. T., Gujral, S., Chacko, K. N. et al: A randomized trial comparing trans-urethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study. J Urol, 164: 65, 2000
6. Netten, A., Dennett, J. and Knight, J.: Unit Costs of Health and Social Care 1998. Canterbury, United Kingdom: University of Kent, 1998
7. Netten, A. and Curtis, L.: Unit Costs of Health and Social Care 2000., Canterbury, United Kingdom: University of Kent, 2000
8. EuroQol - A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16: 199, 1990
9. Drummond, M. F., O'Brien, B. J., Stoddart, G. L. and Torrance, G. W.: Methods for the Economic Evaluation of Health Care Programmes. Oxford, United Kingdom: Oxford University Press, 1997
10. Karlsson, G. and Johannesson M.: The decision rules of cost-effectiveness analysis. Pharmacoeconomics, 9: 113, 1996
11. Keoghane, S. R., Lawrence, K. C., Gray, A. M., Chappel, D. B., Hancock, A. M. and Cranston, D. W.: The Oxford Laser Prostate Trial: Economic issues surrounding contact laser prostatectomy. Br J Urol, 77: 386, 1996
12. Wasson, J. H., Reda, D. J., Bruskewitz, R. C., Elinson, J., Kelldr, A. M. and Henderson, W. G.: A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med, 332: 75, 1995
13. Donovan, J. L., Coast, J. and Peters, T. J.: Treatment for Benign Prostatic Hyperplasia: A Systematic Review. Bristol, United Kingdom: University of Bristol, 1996
14. Wasson, J. H., Bubolz, T. A., Lu-Yao, G. L., Walker-Corkery, E., Hammond, C. S., Barry, M. J. et al: Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. J Urol, 164: 1212, 2000
15. Trueman, P., Hood, S. C., Nayak, U. S. and Mrazek, M. F.: Prevalence of lower urinary tract symptoms and self-reported diagnosed 'benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int, 83: 410, 1999
16. MacDonagh, R. P., Cliff, A. M., Speakman, M. J., OBoyle, P. J., Ewings, P. and Gudex, C.: The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol, 79: 401, 1997
17. Badia, X., Garcia-Losa, M., Dal-Re, R., Carballido, J. and Serra, M.: Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symposium Score. Urology, 52: 614, 1998
18. Donovan, J. L., Kay, H. E., Peters, T. J., Abrams, P., Matos-Ferreira, A., Rentzhog, L. et al: Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' study. International Continence Society - Benign Prostatic Hyperplasia. Br J Urol, 80: 712, 1997
19. Recommendations of the International Consensus Committee. In: Proceedings of the Third International Consultation on BPH. Edited by A. T. K. Cockett, S. Khoury, Y. Aso, C. Chatelain, L. Denis, K. Griffiths et al. World Health Organization, Scientific Communication International, Monaco, June 26-28, 1995, p. 625, 1996